CIK 0001615219 · Non-accelerated filer<br>Smaller reporting company
Decoy Therapeutics Inc.
Sign in to watch- Ticker
- DCOY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465087339
- Phone
- 346-772-0346
- Business address
- 2450 HOLCOMBE BLVD, SUITE J-608, HOUSTON, TX, 77021
- Former names
- Salarius Pharmaceuticals, Inc., Flex Pharma, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-11 | McVicar William K. Director | Purchase · Warrants (right to buy) | +8,700 | $0.01 | $87 | 8,700 |
| 2020-02-11 | HANISH ARNOLD C Director | Purchase · Warrants (right to buy) | +4,350 | $0.01 | $44 | 4,350 |
| 2020-02-11 | McCreedy Bruce J Jr. Director | Purchase · Warrants (right to buy) | +8,700 | $0.01 | $87 | 8,700 |
| 2020-02-11 | McVicar William K. Director | Purchase | +8,700 | $1.15 | $10K | 8,700 |
| 2020-02-11 | Northrup Jonathan P Director | Purchase | +8,700 | $1.15 | $10K | 352,713 |
| 2020-02-11 | Burleson Tess Director | Purchase | +4,350 | $1.15 | $5K | 4,350 |
| 2019-11-25 | HANISH ARNOLD C Director | Purchase | +3,000 | $3.59 | $11K | 3,000 |
Page 6 of 6 · 107 trades